GlassScriptPhysician profile
Scott T Gabriel
NPI 1699757930
$8,445.17
in general payments reported to CMS, 2019-2025
15 companies · $29.36 in 2025
The $29.36 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2021: $34.14 · 2022: $7,185 · 2023: $73.77 · 2024: $880 · 2025: $29.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $975 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $974.81 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,525.04 | 2019-2024 | |
| Avita Medical Americas, LLC | $437.86 | 2024 | |
| Smith+Nephew, INC. | $182.69 | 2022-2023 | Pico |
| Davol INC. | $57.73 | 2019 | |
| Ethicon US, LLC | $52.22 | 2019-2022 | |
| Kerecis Limited | $29.36 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Innovation Technologies INC | $21.59 | 2024 | Irrisept |
| Abbvie INC. | $20.05 | 2023 | |
| Lucid Diagnostics INC. | $19.48 | 2023 | |
| 180 Medical, INC. | $19.04 | 2021 | |
| Merck Sharp & Dohme LLC | $17.25 | 2019 | |
| Covidien LP | $16.25 | 2019 | |
| Acell, INC. | $16.16 | 2019 | |
| Boston Scientific Corporation | $15.35 | 2024 | Spyglass Discover |
| Medtronic, INC. | $15.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Gabriel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.